Ring-shaped cataract and urinary metabolites among 2,4,6-trinitrotoluene exposed population of Pakistan.
Sarwat S, Akhtar A, Dayan SFA, Shaheen N, Durrani HS, Usman T, Afghani T.
Int Ophthalmol. 2022 Aug;42(8):2619-2624. doi: 10.1007/s10792-022-02252-2. Epub 2022 Mar 26.
Trinitrotoluene (TNT)-induced cataract in Danish arms factory workers.
Kruse A, Hertel M, Hindsholm M, Viskum S.
Acta Ophthalmol Scand. 2005 Feb;83(1):26-30. doi: 10.1111/j.1600-0420.2005.00361.x.
[Trinitrotoluene cataract].
Hassman P, Juran J.
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove. 1971;14(2):261-74.
A clinical study of trinitrotoluene cataract.
Zhou AS.
Pol J Occup Med. 1990;3(2):171-6.
[Analysis of eye ultrasonography in patients with trinitrotoluene cataract].
Huang D, Zhu L, Yang J, Wu D.
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2015 Apr;33(4):285-7.
Water quality criteria for 2,4,6-trinitrotoluene.
Ryon MG, Ross RH.
Regul Toxicol Pharmacol. 1990 Apr;11(2):104-13. doi: 10.1016/0273-2300(90)90013-2.
Systemic complications of trinitrotoluene (TNT) in exposed workers.
Naderi M, Ghanei M, Shohrati M, Saburi A, Babaei M, Najafian B.
Cutan Ocul Toxicol. 2013 Mar;32(1):31-4. doi: 10.3109/15569527.2012.699486. Epub 2012 Sep 21.
Hemoglobin adducts, urinary metabolites and health effects in 2,4,6-trinitrotoluene exposed workers.
Sabbioni G, Liu YY, Yan H, Sepai O.
Carcinogenesis. 2005 Jul;26(7):1272-9. doi: 10.1093/carcin/bgi078. Epub 2005 Apr 7.
Monitoring human risk and exposure to trinitrotoluene (TNT) using haemoglobin adducts as biomarkers.
Liu YY, Yao M, Fang JL, Wang YW.
Toxicol Lett. 1995 May;77(1-3):281-7. doi: 10.1016/0378-4274(95)03308-4.
[Cataract in persons working with trinitrotoluene].
Hassman P, Juran J.
Int Arch Arbeitsmed. 1968;24(4):310-8.
